Cotización Nuvectis Pharma - NVCT

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

4.70

Postura de Compra

1.88

Postura de Venta

4.77

Volume Operado de la Acción

110,548

4.53 Rango del Día 4.86

4.52 Rango de 52 semanas 12.10

Capitalización de Mercado [m]

90.809M

Precio Anterior

4.64

Precio de Apertura

4.79

Hora

4.5

Última hora de negociación

Volumen financiero

US$ 519,881

Precio Promedio Ponderado

4.7028

Volumen promedio (3 m)

176,037

Acciones en circulación

19,320,973

Rendimiento del Dividendo

Ratio Precio/Utilidad

-4.10

Beneficio por acción (BPA)

-1.15

turnover

Beneficio neto

-22.26M

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.nuvectis.com

Sede

Wilmington, Delaware, USA

Fundado

Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was US$4.64. Over the last year, Nuvectis Pharma shares have traded in a share price range of US$ 4.52 to US$ 12.10.

Nuvectis Pharma currently has 19,320,973 shares in issue. The market capitalisation of Nuvectis Pharma is US$89.65 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -4.10.

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.12	-2.48962655602	4.82	5.04	4.52	59178	4.74889253	CS
4	-1.01	-17.6882661996	5.71	5.73	4.52	134545	4.97838818	CS
12	-2.01	-29.955290611	6.71	11.8	4.52	176037	6.9273242	CS
26	-1.91	-28.895612708	6.61	11.8	4.52	128109	6.84658336	CS
52	-3.82	-44.8356807512	8.52	12.1	4.52	111253	7.30370108	CS
156	0.75	18.9873417722	3.95	20.92	3.08	189637	7.86269365	CS
260	0.75	18.9873417722	3.95	20.92	3.08	189637	7.86269365	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
WKEYWISeKey International Holdings AG	US$ 7.84 (139.02%)	75.53M
IPHAInnate Pharma SA	US$ 3.00 (93.55%)	13.59M
AVLDirexion Daily AVGO Bull 2X Shares	US$ 33.67 (48.92%)	658.55k
LOOPLoop Industries Inc	US$ 1.8092 (47.09%)	82.56M
AVGXDefiance Daily Target 2X Long AVGO ETF	US$ 31.49 (46.67%)	3.55M
RPTXRepare Therapeutics Inc	US$ 1.765 (-55.54%)	4.7M
INOInovio Pharmaceuticals Inc New	US$ 2.31 (-38.56%)	9.86M
XXII22nd Century Group Inc	US$ 0.048 (-34.69%)	42.23M
FLGCFlora Growth Corporation	US$ 1.30 (-34.34%)	4.14M
WTOUTime Limited	US$ 0.281 (-32.74%)	3.79M
NVDANVIDIA Corporation	US$ 134.25 (-2.25%)	228.17M
SOUNSoundHound AI Inc	US$ 16.905 (23.66%)	158.74M
TRUGTruGolf Holdings Inc	US$ 0.6794 (30.93%)	138.19M
RGTIRigetti Computing Inc	US$ 7.155 (19.85%)	122.67M
AVGOBroadcom Inc	US$ 224.80 (24.43%)	117.74M